ArabFinance: Eva Pharma got the green light to partner with the higher education and agriculture ministries to produce the Chinese vaccine, Sinovac, according to a statement by the cabinet on May 26th.

Eva Pharma was among the companies that agreed with Chinas Sinovac last month to locally manufacture its vaccine, along with Pharco's BioGeneric Pharma and state-owned Vacsera.

The first batch of raw materials that will be used to produce the Chinese jab arrived to Egypt last week.

The country plans to produce 20-60 million doses of the Chinese vaccine each year.

Currently, around 5.25 million individuals in Egypt had registered to receive a vaccine.

Around 1.6 million people, 1.5% of Egypts total population, had received at least one dose of the vaccine as of Sunday, May 23rd.

Egypt reported 1,151 new coronavirus cases on Wednesday, May 26th, raising the total count to 257,275.

Copyright 2021 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an as is and as available basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.